Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial.

Clarke CE, Patel S, Ives N, Rick CE, Dowling F, Woolley R, Wheatley K, Walker MF, Sackley CM; PD REHAB Collaborative Group..

JAMA Neurol. 2016 Mar;73(3):291-9. doi: 10.1001/jamaneurol.2015.4452.

PMID:
26785394
2.

Tracking Parkinson's: Study Design and Baseline Patient Data.

Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND..

J Parkinsons Dis. 2015;5(4):947-59. doi: 10.3233/JPD-150662.

3.

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.

ASPREE Investigator Group..

Contemp Clin Trials. 2013 Nov;36(2):555-64. doi: 10.1016/j.cct.2013.09.014. Epub 2013 Oct 7.

4.

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group., Armitage J, Bowman L, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Peto R, Collins R.

Lancet. 2010 Nov 13;376(9753):1658-69. doi: 10.1016/S0140-6736(10)60310-8. Epub 2010 Nov 8. Erratum in: Lancet. 2011 Jan 8;377(9760):126.

5.

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group., Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R.

JAMA. 2010 Jun 23;303(24):2486-94. doi: 10.1001/jama.2010.840.

PMID:
20571015
6.

SLCO1B1 variants and statin-induced myopathy--a genomewide study.

SEARCH Collaborative Group., Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R.

N Engl J Med. 2008 Aug 21;359(8):789-99. doi: 10.1056/NEJMoa0801936. Epub 2008 Jul 23.

7.
8.

Ras binding to a C-terminal region of GAP.

Molloy DP, Owen D, Grand RJ.

FEBS Lett. 1995 Jul 17;368(2):297-303.

9.

Peptide mimetics of nucleotide phosphate binding sites.

Keane NE, Molloy DP, Grand RJ, Owen D, Levine BA, Ellis L.

Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):267S. No abstract available.

PMID:
8224419
10.

Immunoadsorbent purification of antithrombin: active form and inactive variants.

Molloy C, Owen MC, Boswell DR.

Thromb Res. 1989 Sep 1;55(5):657-60. No abstract available.

PMID:
2683194
11.

The preparation and chemistry of the 10-alpha-estra-4-en-3-ones.

Farkas E, Owen JM, Debono M, Molloy RM, Marsh MM.

Tetrahedron Lett. 1966 Mar;10:1023-7. No abstract available.

PMID:
5927564

Supplemental Content

Loading ...
Support Center